Why Walgreens Boots Alliance Stock Trounced the Market Today
The pharmacy chain operator published its latest set of quarterly results. These results showed growth on both the top and bottom lines.
Walgreens aims to deliver value as consumers seek relief: CEO
Despite beating analyst expectations on both revenue and earnings in its latest second quarter results, Walgreens Boots Alliance (WBA) narrowed its Adjusted EPS guidance for fiscal year 2024, citin...
Walgreens Taps Personalized Marketing to Reach Deal-Seeking Consumers
As economic pressures weigh on shoppers' minds, Walgreens is leveraging its targeting capabilities to keep them engaged. On a call with analysts Thursday (March 28) discussing second-quarter fiscal...
Walgreens CEO on Narrowed Forecast, Shoppers Cutting Back Spending
Walgreens Boots Alliance narrowed its fiscal 2024 guidance citing a challenging retail environment, including reduced consumer spending, and the chain is on track for $1 billion in cost savings. CE...
Walgreens' biggest healthcare bet is floundering as it shutters 160 primary-care clinics
Walgreens' bet on VillageMD continues to flounder. It's exiting 160 VillageMD primary-care clinics, up from the previously planned 60.
Walgreens (WBA) is Seeing a Weak Consumer Environment
Jefferies has a hold rating on Walgreens (WBA). Jefferies' Brian Tanquilut discusses Walgreens most recent earnings.
Walgreens (WBA) Earnings: Turn Around Long Decline?
Walgreens (WBA) 2Q adjusted EPS came in at $1.20 versus an estimated $0.82 and revenue came in at $37.05B versus an estimated $36.48B. Morningstar's Kadyn Kim and Miramar Capital LLC's Max Wasserma...
Walgreens Reports Steep Loss Despite Revenue Beat on Nearly $6 Billion Impairment Charge
Walgreens Boots Alliance (WBA) reported fiscal second-quarter revenue that beat estimates, though it posted a steep loss as it incurred billions of dollars in impairment charges.
Boots UK's sales climb on strong skincare demand
Walgreens Boots Alliance Inc (NASDAQ:WBA, ETR:W8A)'s UK division, Boots, enjoyed a 3% rise in sales over the three months to February. This was as in-store sales climbed 4.5%, while digital sales j...
Compared to Estimates, Walgreens (WBA) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Walgreens (WBA) give a sense of how its business performed in the quarter ended February 2024, it might be worth considering how some key metrics compare with Wall ...
Walgreens' quarterly results hit by $5.8B VillageMD impairment charge
Walgreens Boots Alliance Inc (NASDAQ:WBA, ETR:W8A)'s fiscal second quarter results took a $5.8 billion hit from impairment charges on its investment in medical clinic operator VillageMD, sending it...
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Walgreens Boots Alliance's NASDAQ: WBA efforts are paying off, although they still have work to do. The company's leaning toward efficiency and efforts to reinvigorate growth, sustain growth and im...
Walgreens Boots Alliance (WBA) Q2 Earnings and Revenues Beat Estimates
Walgreens Boots Alliance (WBA) came out with quarterly earnings of $1.20 per share, beating the Zacks Consensus Estimate of $0.82 per share. This compares to earnings of $1.16 per share a year ago.
Walgreens tops quarterly revenue estimates, but narrows profit outlook in ‘challenging' economy
CNBC's Bertha Coombs joins 'Squawk Box' to break down the company's quarterly earnings results.
Related Companies